Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_759_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
47 Мб
Скачать
342
C. Lam and M. M. Leitao
of fecal incontinence, particularly in patients with previous irradiation. The digital rectal examination is a rudimentary way to assess qual­ity of anal tone. Fecal incontinence has been evaluated using anorectal manometry, pudendal nerve latency studies, and electromyography [55]. The Wexner fecal incontinence scale is likely the most widely used tool to assess for presence of fecal incontinence and to measure the severity of symptoms.
Prevention ofFunctional Impairments After Radical Vulvectomy
Radical vulvectomy by itself does not cause incontinence, but according to a prospective study of 21 patients who underwent a radical vul­vectomy, removal of a portion of the urethra is a risk factor for urinary incontinence, with esti­mated rates of severe/total urinary incontinence ranging from 22% to 100% [85]. Appropriate patient selection based on imaging and examina­tion ndings, as well as adequate preoperative and postoperative patient counseling, are recom­mended for all patients. Resection of the external anal sphincter is a risk factor for postoperative fecal incontinence. According to one retrospec­tive study, two patients with resection of most of the anus developed severe fecal incontinence postoperatively, four of eight patients with partial resection of the external anal sphincter developed persistent postoperative fecal incontinence, and no patients with preserved external anal sphincter developed new-onset postoperative fecal inconti­nence [50]. Extensive perianal resection followed by primary anal reconstruction using local skin aps, such as unilateral or bilateral rhomboid aps or local advancement aps, should be con­sidered for preservation of fecal continence [9,
49]. Primary repair of the external anal sphincter
by anal sphincteroplasty, most commonly used in the setting of obstetrical lacerations, can also be considered at the time of radical vulvectomy to preserve function of the external anal sphincter and to prevent postoperative fecal incontinence. Among the obstetric population, postoperative
results are felt to be better with delayed repair rather than primary repair, which is likely due to edematous tissues [35]; however, this may not apply to oncologic procedures involving resec­tion of the anal sphincter.
Although the primary aim of surgery is to achieve local control of cancer or precancerous lesions, as alluded to above, vulvar reconstruc­tion has also become an area of interest for improved outcomes for our patients. Reconstructive surgery can provide aesthetic and functional benets while maintaining the integ­rity of the oncologic resection with safe surgical margins. In large defects, wound closure with reconstructive aps is suggested to be superior to direct wound closure for cosmetic and functional purposes.
Various aps have been evaluated for recon­struction after extensive vulvovaginal carcinoma surgery. Of 12 patients with gynecologic cancer who underwent vulvovaginal surgery with simul­taneous reconstruction, seven maintained satis­factory sexual function postoperatively. All of these patients had been treated with the inner­vated pudendal-thigh ap [61]. In this study, the gracilis myocutaneous ap was thought to be bet­ter suited for patients with a large defect after excision procedure. In a systematic review of various fascio-cutaneous aps for vulvovaginal reconstruction, the lotus petal ap, which includes the pudendal nerves in the pedicle, the gluteal-fold fascio-cutaneous ap (Fig. 31.5), which includes the cutaneous branches of the internal pudendal nerve, the V-Y advancement gluteal-fold ap (Fig. 31.6), which includes branches of the cutaneous nerve from the femoral and obturator nerves, and the medial thigh fascio­cutaneous ap all support restoration of sensitiv­ity in the area, and, therefore have the potential to promote satisfactory sexual function after sur­gery [26]. One cross-sectional study assessing quality of life and sexual function after vulvo­vaginal surgery with concurrent lotus petal ap procedure demonstrated overall satisfaction in sexual function in this patient population [44]; this nding has been conrmed in other studies [93]. Additionally, compared to the V-Y advance­ment ap, the lotus petal ap was deemed to be
31 Inguinal Lymphadenectomy, Radical Vulvectomy
Fig. 31.5 Gluteus fasciocutaneous rotational ap. (Courtesy of Dr. Mario M.Leitao, Jr.)
343
Fig. 31.6 V-Y advancement ap (Courtesy of Dr. Mario M. Leitao, Jr.)
superior in terms of functional and cosmetic results in patients who underwent vulvovaginal oncologic surgery [20].
Several algorithms have been proposed to help surgeons determine the best reconstructive plan [92, 54, 31, 91, 34]. Further data of postoperative outcomes, specically sexual function, are neces­sary to inform physicians and patients alike.
Postoperative sexual function after extensive perineal excision may be particularly compro-
mised due to posterior introital scarring. Many aps have been evaluated in the closure of peri­neal defects specically, including the inferior gluteal ap, V-Y ap, lotus petal ap, and rhomboid transposition ap [16, 45, 67, 93]. Repair of perineal defects after radical vulvar surgery is best performed with skin aps versus direct closure to reduce postoperative morbid­ity and provide better anatomical and functional results [62].
344
C. Lam and M. M. Leitao
Management ofFunctional Impairments After Radical Vulvectomy
Urinary incontinence related to anatomical dis­tortions from radical vulvectomy warrants a dif­ferent treatment approach. Urethral resection is sometimes necessary in the surgical treatment of locally advanced vulvar cancer, which leads to a pathology similar to type III stress urinary incon­tinence related to intrinsic sphincter deciency. Management options for urinary incontinence due to radical vulvectomy with urethrectomy are similar to those used to treat intrinsic sphincter deciency. This includes articial sphincter implantation, pubovaginal sling, midurethral tension- free vaginal tape, or bulking agent injec­tion. One unique treatment modality is transure­thral Macroplastique implantation, which was shown to be safe and effective in oncologic patients with total urinary incontinence after rad­ical vulvar surgery [76].
Urethral eversion can be seen specically after a radical vulvectomy. It is important to per­form a thorough physical examination to rule this out, as urethral eversion is a cause of urinary incontinence and general difculty with micturi­tion can be managed surgically. In one case report, a patient who underwent radical vulvec­tomy with direct wound closure presented with severe pain due to urethral orice eversion one year after primary surgery; the patient subse­quently underwent a secondary vulvar recon­struction using bilateral gluteal-fold aps three years after primary surgery [86]. Although pri­mary reconstruction is ideal, this case report sup­ports the feasibility of secondary reconstruction should it be necessary.
Fecal incontinence after radical vulvectomy is most commonly observed in patients with anal sphincter resection or damage. Conservative measures should be attempted rst; these include dietary adjustments, ber supplementation or other bulking agents, constipating agents, anal plugs, and biofeedback therapy [28]. Avoiding food and drink that cause loose stool or increas­ing the intake of constipating agents are key
dietary adjustments that have been shown to be effective in some cases of fecal incontinence. Fiber and bulking agents, such as psyllium, methyl cellulose, and synthetic polycarbophil, can change stool consistency to decrease symp­toms of fecal incontinence [12, 102]. Loperamide increases anal resting pressure, impairs the recto­anal inhibitory reex, and increases transit time in the small and large intestines, and has been well-documented to have efcacy in cases of fecal incontinence associated with loose stool [43, 63, 69, 71, 84, 88]. Pelvic oor rehabilitation plays a crucial role in the management of anal incontinence, often in conjunction with surgical procedures such as sphincteroplasty [75].
Pudendal nerve terminal motor latencies can be used to assess pudendal neuropathy. Once standard evaluation has been completed, if the determined etiology of fecal incontinence is not pudendal neuropathy, sphincteroplasty may be an option to restore anal continence, depending on the availability of the anal sphincter muscle. If there is inadequate sphincter muscle due to resec­tion, encirclement procedures using synthetic materials or muscle transfer techniques can be employed. Implantation of a stimulating elec­trode can be helpful in certain clinical scenarios, particularly when using a gracilis neosphincter or articial sphincter [55]. Sacral nerve stimulation and posterior tibial nerve modulation are neuro­modulatory techniques that can decrease inconti­nence episodes, and there does not seem to be a difference in efcacy between the two methods [103]. Antegrade colonic irrigation through an appendicostomy was rst described in children but has been shown to have some long-term ef­cacy in adults [65, 77]. Fecal diversion can be pursued if all other options are exhausted, or if the patient desires this option or is not a candi­date for other therapeutic options.
General emotional support in the preoperative and postoperative phases has been shown to be necessary for patients who undergo surgical treatment for vulvar cancer [7]. With depression and anxiety affecting up to one-third of all patients with vulvar cancer, the complex correla­tion between psychosocial status and sexual dys-
31 Inguinal Lymphadenectomy, Radical Vulvectomy
345
function cannot be ignored [68]. Preoperative relational dissatisfaction is more common in patients with vulvar malignancy and can continue or even worsen postoperatively, regardless of the extent of surgical excision [8, 68]. Depending on the type of sexual dysfunction the patient pres­ents with, psychotherapy can be tailored to t their needs.
In addition to psychosocial risk factors, ana­tomic distortions can also contribute to sexual dysfunction in patients with vulvar cancer. Introital stenosis is one such example that can occur after vulvectomy. As in the case of urethral eversion, introital stenosis can also be managed surgically if conservative treatment with dilators is not sufcient to provide adequate relief of symptoms. A case report demonstrated the lotus petal ap was a safe and effective technique for reconstruction in the case of severe introital ste­nosis after primary vulvovaginal surgery with direct wound closure [15]. Given the crucial role of the clitoris in sexual function, clitoral-sparing surgical procedures have been evaluated for safety and efcacy in the management of vulvar carcinomas. One retrospective study examining clitoral- sparing modied vulvectomies found no loco- regional recurrences [17]. In fact, when compared to complete radical vulvectomy, mod­ied radical vulvectomy is generally associated with the same rate of recurrence and decreased risk of sexual dysfunction [27, 30, 96]. One ret­rospective study, however, demonstrated an increased risk of loco- regional recurrence after wide local excision compared to radical vulvec­tomy, suggesting that less radical surgery was associated with a higher risk of recurrence. Although, in this study, there was no difference in survival between the two groups, which sug­gests that such loco-regional recurrences can be successfully salvaged [24]. Thus, clitoral-spar­ing surgery can preserve sexual function while maintaining oncologic integrity of the excisional procedure.
Physiological changes, present both preopera­tively and potentially enhanced postoperatively, including anorgasmia, difculty in lubrication, and pain, can contribute to sexual dysfunction and should be addressed as indicated [68].

References

1. Abbas S, Seitz M. Systematic review and meta­analysis of the used surgical techniques to reduce leg lymphedema following radical inguinal nodes dissection. Surg Oncol. 2011;20:88–96. https://doi.
org/10.1016/j.suronc.2009.11.003.
2. Aerts L, Enzlin P, Vergote I, etal. Sexual, psycho­logical, and relational functioning in women after surgical treatment for vulvar malignancy: a litera­ture review. J Sex Med. 2012;9:361–71. https://doi.
org/10.1111/j.1743- 6109.2011.02520.x.
3. Aerts L, Enzlin P, Verhaeghe J, et al. Psychologic, relational, and sexual functioning in women after surgical treatment of vulvar malignancy: a prospective controlled study. Int J Gynecol Cancer. 2014;24:372–80. https://doi.org/10.1097/
IGC.0000000000000035.
4. Allam O, Park KE, Chandler L, et al. The impact of radiation on lymphedema: a review of the lit­erature. Gland Surg. 2020;9:596–602. https://doi.
org/10.21037/gs.2020.03.20.
5. American College of Obstetricians and Gynecologists Women’s Health Care Physicians, Committee on Gynecologic Practice. Committee opinion no. 571: solutions for surgical prep­aration of the vagina. Obstet Gynecol. 2013;122:718–20. https://doi.org/10.1097/01.
AOG.0000433982.36184.95.
6. Asciutto KC, Acosta S, Borgfeldt C. Negative Pressure Wound Therapy (NPWT) in groin wounds after lymphadenectomy in vulvar cancer patients. Vivo Athens Greece. 2020;34:3511–7. https://doi.
org/10.21873/invivo.12192.
7. Avery W, Gardner C, Palmer S. Vulvectomy. Am J Nurs. 1974;74:453–5.
8. Barlow EL, Hacker NF, Hussain R, Parmenter G.Sexuality and body image following treatment for early-stage vulvar cancer: a qualitative study. J Adv Nurs. 2014;70:1856–66. https://doi.org/10.1111/
jan.12346.
9. Barton DPJ, Hoffman MS, Roberts WS, etal. Use of local aps in the preservation of fecal conti­nence following resection of perianal neoplasias. Int J Gynecol Cancer. 1993;3:318–23. https://doi.
org/10.1046/j.1525- 1438.1993.03050318.x.
10. Beitsch P, Balch C. Operative morbidity and risk factor assessment in melanoma patients under­going inguinal lymph node dissection. Am J Surg. 1992;164:462–6. https://doi.org/10.1016/
S0002- 9610(05)81181- X.
11. Benoit L, Boichot C, Cheynel N, etal. Preventing lymphedema and morbidity with an omentum ap after ilioinguinal lymph node dissection. Ann Surg Oncol. 2005;12:793–9. https://doi.org/10.1245/
ASO.2005.09.022.
12. Bliss DZ, Jung HJ, Savik K, etal. Supplementation with dietary ber improves fecal inconti­nence. Nurs Res. 2001;50:203–13. https://doi.
org/10.1097/00006199- 200107000- 00004.
346
C. Lam and M. M. Leitao
13. Boyages J, Kastanias K, Koelmeyer LA, et al. Liposuction for advanced lymphedema: a multidis­ciplinary approach for complete reduction of arm and leg swelling. Ann Surg Oncol. 2015;22(Suppl
3):S1263–70. https://doi.org/10.1245/
s10434- 015- 4700- 3.
14. Brorson H. Liposuction in lymphedema treatment. J Reconstr Microsurg. 2016;32:56–65. https://doi.
org/10.1055/s- 0035- 1549158.
15. Buda A, Confalonieri PL, Rovati LCV, et al. Tunneled modied lotus petal ap for surgical reconstruction of severe introital stenosis after radical vulvectomy. Int J Surg Case Rep. 2012;3:299–301. https://doi.org/10.1016/j.
ijscr.2012.03.024.
16. Carramaschi F, Ramos ML, Nisida AC, et al. V-Y ap for perineal reconstruction following modi­ed approach to vulvectomy in vulvar cancer. Int J Gynaecol Obstet. 1999;65:157–63. https://doi.
org/10.1016/s0020- 7292(99)00016- 8.
17. Chan JK, Sugiyama V, Tajalli TR, etal. Conservative clitoral preservation surgery in the treatment of vulvar squamous cell carcinoma. Gynecol Oncol. 2004;95:152–6. https://doi.org/10.1016/j.
ygyno.2004.07.004.
18. Chang DW.Lymphaticovenular bypass for lymph­edema management in breast cancer patients: a pro­spective study. Plast Reconstr Surg. 2010;126:752–8.
https://doi.org/10.1097/PRS.0b013e3181e5f6a9.
19. Cheng M-H, Chen S-C, Henry SL, et al. Vascularized groin lymph node ap transfer for postmastectomy upper limb lymphedema: ap anat­omy, recipient sites, and outcomes. Plast Reconstr Surg. 2013;131:1286–98. https://doi.org/10.1097/
PRS.0b013e31828bd3b3.
20. Confalonieri PL, Gilardi R, Rovati LC, et al. Comparison of V-Y advancement ap versus lotus petal ap for plastic reconstruction after surgery in case of vulvar malignancies: a retrospective single center experience. Ann Plast Surg. 2017;79:186–91.
https://doi.org/10.1097/SAP.0000000000001094.
21. Courtney-Brooks M, Scalici J, Henretta MS, etal. Vulvar necrotizing soft tissue infection: a review of a multi-disciplinary surgical emergency and management in the modern era. Gynecol Oncol Case Rep. 2013;5:6–9. https://doi.org/10.1016/j.
gynor.2013.02.002.
22. Damstra RJ, Voesten HGJ, van Schelven WD, van der Lei B. Lymphatic venous anastomosis (LVA) for treatment of secondary arm lymphedema. A pro­spective study of 11 LVA procedures in 10 patients with breast cancer related lymphedema and a critical review of the literature. Breast Cancer Res Treat. 2009;113:199–206. https://doi.org/10.1007/
s10549- 008- 9932- 5.
23. Dardarian TS, Gray HJ, Morgan MA, et al. Saphenous vein sparing during inguinal lymphade­nectomy to reduce morbidity in patients with vulvar carcinoma. Gynecol Oncol. 2006;101:140–2. https://
doi.org/10.1016/j.ygyno.2005.10.002.
24. De Hullu JA, Hollema H, Lolkema S, etal. Vulvar carcinoma: the price of less radical surgery. Cancer. 2002;95:2331–8. https://doi.org/10.1002/
cncr.10969.
25. Dessources K, Aviki E, Leitao MM Jr. Lower extrem­ity lymphedema in patients with gynecologic malig­nancies. Int J Gynecol Cancer. 2020;30(2):252–260.
https://doi.org/10.1136/ijgc-2019-001032.
26. Di Donato V, Bracchi C, Cigna E, et al. Vulvo­vaginal reconstruction after radical excision for treatment of vulvar cancer: evaluation of feasibility and morbidity of different surgical techniques. Surg Oncol. 2017;26:511–21. https://doi.org/10.1016/j.
suronc.2017.10.002.
27. DiSaia PJ, Creasman WT, Rich WM. An alter­nate approach to early cancer of the vulva. Am J Obstet Gynecol. 1979;133:825–32. https://doi.
org/10.1016/0002- 9378(79)90119- 4.
28. Duelund-Jakobsen J, Worsoe J, Lundby L, et al. Management of patients with faecal incontinence. Ther Adv Gastroenterol. 2016;9:86–97. https://doi.
org/10.1177/1756283X15614516.
29. Elg SA, Carson LF, Brooker DC, et al. Infectious morbidity after radical vulvectomy. Infect Dis Obstet Gynecol. 1994;2:130–5. https://doi.org/10.1155/
S1064744994000529.
30. Farias-Eisner R, Cirisano FD, Grouse D, et al. Conservative and individualized surgery for early squamous carcinoma of the vulva: the treatment of choice for stage I and II (T1-2 N0-1 M0) dis­ease. Gynecol Oncol. 1994;53:55–8. https://doi.
org/10.1006/gyno.1994.1087.
31. Friedman J, Dinh T, Potochny J. Reconstruction of the perineum. Semin Surg Oncol. 2000;19:282–93. https://doi.org/10.1002/1098-
2388(200010/11)19:3<282::aid- ssu10>3.0.co;2- b.
32. Furukawa H, Osawa M, Saito A, etal. Microsurgical lymphaticovenous implantation targeting der­mal lymphatic backow using indocyanine green uorescence lymphography in the treatment of postmastectomy lymphedema. Plast Reconstr Surg. 2011;127:1804–11. https://doi.org/10.1097/
PRS.0b013e31820cf2e2.
33. Gaarenstroom KN, Kenter GG, Trimbos JB, et al. Postoperative complications after vul­vectomy and inguinofemoral lymphadenec­tomy using separate groin incisions. Int J Gynecol Cancer. 2003;13:522–7. https://doi.
org/10.1046/j.1525- 1438.2003.13304.x.
34. Gentileschi S, Servillo M, Garganese G, etal. Surgical therapy of vulvar cancer: how to choose the cor­rect reconstruction? J Gynecol Oncol. 2016;27:e60.
https://doi.org/10.3802/jgo.2016.27.e60.
35. Goetz LH, Lowry AC.Overlapping sphincteroplasty: is it the standard of care? Clin Colon Rectal Surg. 2005;18:22. https://doi.org/10.1055/s- 2005- 864072.
36. Gopman JM, Djajadiningrat RS, Baumgarten AS, et al. Predicting postoperative complications of inguinal lymph node dissection for penile can­cer in an international multicentre cohort. BJU
31 Inguinal Lymphadenectomy, Radical Vulvectomy
347
Int. 2015;116:196–201. https://doi.org/10.1111/
bju.13009.
37. Gould N, Kamelle S, Tillmanns T, et al. Predictors of complications after inguinal lymphadenec­tomy. Gynecol Oncol. 2001;82:329–32. https://doi.
org/10.1006/gyno.2001.6266.
38. Green MS, Naumann RW, Elliot M, et al. Sexual dysfunction following vulvectomy. Gynecol Oncol. 2000;77:73–7. https://doi.org/10.1006/
gyno.2000.5745.
39. Greene AK, Goss JA. Diagnosis and staging of lymphedema. Semin Plast Surg. 2018;32:12–6.
https://doi.org/10.1055/s- 0038- 1635117.
40. Gupta MK, Patel AP, Master VA.Technical consider­ations to minimize complications of inguinal lymph node dissection. Transl Androl Urol. 2017;6:820–5.
https://doi.org/10.21037/tau.2017.06.06.
41. Hacker NF, Leuchter RS, Berek JS, et al. Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet Gynecol. 1981;58:574–9.
42. Hanauer SB. The role of loperamide in gastro­intestinal disorders. Rev Gastroenterol Disord. 2008;8:15–20.
43. Hellinga J, te Grootenhuis NC, Werker PMN, etal. Quality of life and sexual functioning after vulvar reconstruction with the lotus petal ap. Int J Gynecol Cancer. 2018;28(9):1728. https://doi.org/10.1097/
IGC.0000000000001340.
44. Helm CW, Hatch KD, Partridge EE, Shingleton HM. The rhomboid transposition ap for repair of the perineal defect after radical vulvar sur­gery. Gynecol Oncol. 1993;50:164–7. https://doi.
org/10.1006/gyno.1993.1186.
45. Hill AM, Pauls RN, Basil J, et al. Chlorhexidine versus iodine for vaginal preparation before hyster­ectomy: a randomized clinical trial. Urogynecology. 2022;28:77. https://doi.org/10.1097/
SPV.0000000000001066.
46. Hnin YK, Ong LX, Tsai CC-C, et al. Does initial routine use of a compression garment reduce the risk of lower limb lymphedema after gynecological can­cer treatment? A randomized pilot study in an Asian institution and review of the literature. Lymphology. 2018;51:174–83.
47. Höckel M, Dornhöfer N.Vulvovaginal reconstruction for neoplastic disease. Lancet Oncol. 2008;9:559–68.
https://doi.org/10.1016/S1470- 2045(08)70147- 5.
48. Hoffman MS, LaPolla JP, Roberts WS, et al. Use of local aps for primary anal reconstruc­tion following perianal resection for neoplasia. Gynecol Oncol. 1990;36:348–52. https://doi.
org/10.1016/0090- 8258(90)90140- g.
49. Hoffman MS, Roberts WS, LaPolla JP, et al. Carcinoma of the vulva involving the perianal or anal skin. Gynecol Oncol. 1989;35:215–8. https://
doi.org/10.1016/0090- 8258(89)90046- 2.
50. Homesley HD, Bundy BN, Sedlis A, Adcock L. Radiation therapy versus pelvic node resection
for carcinoma of the vulva with positive groin nodes. Obstet Gynecol. 1986;68:733–40.
51. Ince C, Temple-Oberle C, Leitao MM, et al. Immediate lymphatic reconstruction: the time is right to prevent lymphedema following lymph­adenectomy for vulvar cancer. Int J Gynecol Cancer. 2021;31:943. https://doi.org/10.1136/
ijgc- 2021- 002666.
52. International Society of Lymphology. The diagno­sis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology. Lymphology. 2013;46:1–11.
53. John HE, Jessop ZM, Di Candia M, etal. An algo­rithmic approach to perineal reconstruction after cancer resection—experience from two international centers. Ann Plast Surg. 2013;71:96–102. https://
doi.org/10.1097/SAP.0b013e3182414485.
54. Jorge JM, Wexner SD. Etiology and manage­ment of fecal incontinence. Dis Colon Rectum. 1993;36:77–97. https://doi.org/10.1007/
BF02050307.
55. Jørgensen MG, Toyserkani NM, Sørensen JA.The effect of prophylactic lymphovenous anastomosis and shunts for preventing cancer-related lymph­edema: a systematic review and meta- analysis. Microsurgery. 2018;38:576–85. https://doi.
org/10.1002/micr.30180.
56. Josephson DY, Jacobsohn KM, Link BA, Wilson TG. Robotic-assisted endoscopic inguinal lymph­adenectomy. Urology. 2009;73:167–70; dis­cussion 170–171. https://doi.org/10.1016/j.
urology.2008.05.060.
57. Klemm P, Marnitz S, Köhler C, etal. Clinical impli­cation of laparoscopic pelvic lymphadenectomy in patients with vulvar cancer and positive groin nodes. Gynecol Oncol. 2005;99:101–5. https://doi.
org/10.1016/j.ygyno.2005.05.027.
58. Koshima I, Inagawa K, Urushibara K, Moriguchi T. Supermicrosurgical lymphaticovenular anasto­mosis for the treatment of lymphedema in the upper extremities. J Reconstr Microsurg. 2000;16:437–42.
https://doi.org/10.1055/s- 2006- 947150.
59. Kung TA, Champaneria MC, Maki JH, Neligan PC. Current concepts in the surgical Management of Lymphedema. Plast Reconstr Surg. 2017;139:1003e. https://doi.org/10.1097/
PRS.0000000000003218.
60. Lai YL, Chang CJ.Vulvovaginal reconstruction fol­lowing radical tumor resection: report of 12 cases. Chang Yi Xue Za Zhi. 1999;22:253–8.
61. Landoni F, Proserpio M, Maneo A, et al. Repair of the perineal defect after radical vulvar surgery: direct closure versus skin aps reconstruction. A retrospective comparative study. Aust N Z J Obstet Gynaecol. 1995;35:300–4. https://doi.org/10.1111/
j.1479- 828x.1995.tb01987.x.
62. Lauti M, Scott D, Thompson-Fawcett MW. Fibre supplementation in addition to loperamide for faecal incontinence in adults: a randomized
348
C. Lam and M. M. Leitao
trial. Color Dis. 2008;10:553–62. https://doi.
org/10.1111/j.1463- 1318.2007.01439.x.
63. Le A, Xiong J, Wang Z, et al. Endoscopy-assisted inguinal lymphadenectomy in vulvar cancer. Arch Gynecol Obstet. 2018;297:1277–83. https://doi.
org/10.1007/s00404- 018- 4732- 6.
64. Lefèvre JH, Parc Y, Giraudo G, etal. Outcome of antegrade continence enema procedures for faecal incontinence in adults. Br J Surg. 2006;93:1265–9.
https://doi.org/10.1002/bjs.5383.
65. Leung N, Furniss D, Giele H. Modern surgi­cal management of breast cancer therapy related upper limb and breast lymphoedema. Maturitas. 2015;80:384–90. https://doi.org/10.1016/j.
maturitas.2015.01.012.
66. Loree TR, Hempling RE, Eltabbakh GH, etal. The inferior gluteal ap in the difcult vulvar and perineal reconstruction. Gynecol Oncol. 1997;66:429–34.
https://doi.org/10.1006/gyno.1997.4790.
67. Malandrone F, Bevilacqua F, Merola M, etal. The impact of vulvar cancer on psychosocial and sexual functioning: a literature review. Cancers. 2022;14:63.
https://doi.org/10.3390/cancers14010063.
68. Musial F, Enck P, Kalveram KT, Erckenbrecht JF. The effect of loperamide on anorec­tal function in normal healthy men. J Clin Gastroenterol. 1992;15:321–4. https://doi.
org/10.1097/00004836- 199212000- 00011.
69. Oladokun A, Babarinsa IA, Adewole IF, etal. A Sitz bath does not improve wound healing after elec­tive episiotomy. J Obstet Gynaecol. 2000;20:277–9.
https://doi.org/10.1080/01443610050009601.
70. Ooms LA, Degryse AD, Janssen PA.Mechanisms of action of loperamide. Scand J Gastroenterol Suppl. 1984;96:145–55.
71. Oonk MHM, Slomovitz B, Baldwin PJW, et al. Radiotherapy versus inguinofemoral lymphadenec­tomy as treatment for vulvar cancer patients with micrometastases in the sentinel node: results of GROINSS-V II. J Clin Oncol Off J Am Soc Clin Oncol. 2021;39:3623–32. https://doi.org/10.1200/
JCO.21.00006.
72. Oremus M, Dayes I, Walker K, Raina P.Systematic review: conservative treatments for secondary lymphedema. BMC Cancer. 2012;12:6. https://doi.
org/10.1186/1471- 2407- 12- 6.
73. Patel KM, Lin C-Y, Cheng M-H. A prospective evaluation of lymphedema-specic quality-of-life outcomes following vascularized lymph node trans­fer. Ann Surg Oncol. 2015;22:2424–30. https://doi.
org/10.1245/s10434- 014- 4276- 3.
74. Pescatori LC, Pescatori M. Sphincteroplasty for anal incontinence. Gastroenterol Rep. 2014;2:92–7.
https://doi.org/10.1093/gastro/gou003.
75. Plotti F, Zullo MA, Palaia I, et al. Urinary incon­tinence after radical vulvectomy treated with macroplastique implantation. J Minim Invasive Gynecol. 2008;15:113–5. https://doi.org/10.1016/j.
jmig.2007.08.607.
76. Poirier M, Abcarian H, Nelson R. Malone ante­grade continent enema: an alternative to resec­tion in severe defecation disorders. Dis Colon Rectum. 2007;50:22–8. https://doi.org/10.1007/
s10350- 006- 0732- x.
77. Pons G, Masia J, Loschi P, etal. A case of donor­site lymphoedema after lymph node-supercial cir­cumex iliac artery perforator ap transfer. J Plast Reconstr Aesthet Surg. 2014;67:119–23. https://doi.
org/10.1016/j.bjps.2013.06.005.
78. Pontre J, Harding J, Chivers P, etal. Do groin drains reduce postoperative morbidity in women under­going Inguinofemoral lymphadenectomy for vul­var cancer? Int J Gynecol Cancer. 2018;28:183–7.
https://doi.org/10.1097/IGC.0000000000001146.
79. Pouwer A-FW, Arts HJ, Koopmans CM, et al. Reduced morbidity by using LigaSure compared to conventional inguinofemoral lymphadenectomy in vulvar cancer patients: a randomized controlled trial. Surg Oncol. 2020;35:149–55. https://doi.
org/10.1016/j.suronc.2020.08.011.
80. Pouwer A-FW, Arts HJ, van der Velden J, de Hullu JA. Limiting the morbidity of inguino­femoral lymphadenectomy in vulvar cancer patients; a review. Expert Rev Anticancer Ther. 2017a;17:615–24. https://doi.org/10.1080/1473714
0.2017.1337513.
81. Pouwer AW, Hinten F, van der Velden J, et al. Volume-controlled versus short drainage after inguinofemoral lymphadenectomy in vulvar can­cer patients: a Dutch nationwide prospective study. Gynecol Oncol. 2017b;146:580–7. https://doi.
org/10.1016/j.ygyno.2017.06.031.
82. Raju A, Chang DW.Vascularized lymph node trans­fer for treatment of lymphedema: a comprehensive literature review. Ann Surg. 2015;261:1013–23.
https://doi.org/10.1097/SLA.0000000000000763.
83. Read M, Read NW, Barber DC, Duthie HL.Effects of loperamide on anal sphincter function in patients complaining of chronic diarrhea with fecal inconti­nence and urgency. Dig Dis Sci. 1982;27:807–14.
https://doi.org/10.1007/BF01391374.
84. Reid GC, DeLANCEY JOL, Hopkins MP, et al. Urinary incontinence following radical vulvectomy. Obstet Gynecol. 1990;75:852.
85. Roh S, Miyamoto S, Kitamura Y, et al. Secondary vulvar reconstruction using bilateral gluteal fold aps after radical vulvectomy with direct closure. Plast Reconstr Surg Glob Open. 2021;9:e3550.
https://doi.org/10.1097/GOX.0000000000003550.
86. Rouzier R, Haddad B, Dubernard G, et al. Inguinofemoral dissection for carcinoma of the vulva: effect of modications of extent and tech­nique on morbidity and survival. J Am Coll Surg. 2003;196:442–50. https://doi.org/10.1016/
S1072- 7515(02)01895- 1.
87. Ruppin H. Review: loperamide—a potent antidiar­rhoeal drug with actions along the alimentary tract. Aliment Pharmacol Ther. 1987;1:179–90. https://
doi.org/10.1111/j.1365- 2036.1987.tb00617.x.
31 Inguinal Lymphadenectomy, Radical Vulvectomy
349
88. Russell CM, Salami SS, Niemann A, etal. Minimally invasive inguinal lymphadenectomy in the manage­ment of penile carcinoma. Urology. 2017;106:113–8.
https://doi.org/10.1016/j.urology.2017.04.022.
89. Rutledge TL, Heckman SR, Qualls C, etal. Pelvic oor disorders and sexual function in gyneco­logic cancer survivors: a cohort study. Am J Obstet Gynecol. 2010;203:514.e1–7. https://doi.
org/10.1016/j.ajog.2010.08.004.
90. Saleh DB, Liddington MI, Loughenbury P, et al. Reconstruction of the irradiated perineum follow­ing extended abdomino-perineal excision for cancer: an algorithmic approach. J Plast Reconstr Aesthet Surg. 2012;65:1537–43. https://doi.org/10.1016/j.
bjps.2012.05.011.
91. Salgarello M, Farallo E, Barone-Adesi L, et al. Flap algorithm in vulvar reconstruction after radical, extensive vulvectomy. Ann Plast Surg. 2005;54:184–90. https://doi.org/10.1097/01.
sap.0000141381.77762.07.
92. Sawada M, Kimata Y, Kasamatsu T, etal. Versatile lotus petal ap for vulvoperineal reconstruction after gynecological ablative surgery. Gynecol Oncol. 2004;95:330–5. https://doi.org/10.1016/j.
ygyno.2004.07.038.
93. Schimp VL, Worley C, Brunello S, etal. Vacuum­assisted closure in the treatment of gyneco­logic oncology wound failures. Gynecol Oncol. 2004;92:586–91. https://doi.org/10.1016/j.
ygyno.2003.10.055.
94. Shallwani SM, Towers A, Newman A, et al. Feasibility of a pilot randomized controlled trial examining a multidimensional intervention in women with gynecological cancer at risk of lymph­edema. Curr Oncol. 2021;28:455–70. https://doi.
org/10.3390/curroncol28010048.
95. Siller BS, Alvarez RD, Conner WD, etal. T2/3 vulva cancer: a case-control study of triple incision versus en bloc radical vulvectomy and inguinal lymphad­enectomy. Gynecol Oncol. 1995;57:335–9. https://
doi.org/10.1006/gyno.1995.1152.
96. Skeith AE, Morgan DM, Schmidt PC.Vaginal prepa­ration with povidone-iodine or chlorhexidine before hysterectomy: a propensity score matched analysis. Am J Obstet Gynecol. 2021;225:560.e1–9. https://
doi.org/10.1016/j.ajog.2021.08.035.
97. Söderman M, Thomsen JB, Sørensen JA. Complications following inguinal and ilioin­guinal lymphadenectomies: a meta-analysis. J Plast Surg Hand Surg. 2016;50:315–20. https://doi.org/10
.3109/2000656X.2016.1173560.
98. Strugala V, Martin R. Meta-analysis of compara­tive trials evaluating a prophylactic single-use negative pressure wound therapy system for the prevention of surgical site complications. Surg Infect. 2017;18:810–9. https://doi.org/10.1089/
sur.2017.156.
99. Stuiver MM, de Rooij JD, Lucas C, etal. No evi­dence of benet from class-II compression stock­ings in the prevention of lower-limb lymphedema after inguinal lymph node dissection: results of a randomized controlled trial. Lymphology. 2013;46:120–31.
100. Sulo E, Hartiala P, Viitanen T, etal. Risk of donor­site lymphatic vessel dysfunction after microvas­cular lymph node transfer. J Plast Reconstr Aesthet Surg. 2015;68:551–8. https://doi.org/10.1016/j.
bjps.2014.11.016.
101. Sze EHM, Hobbs G.Efcacy of methylcellulose and loperamide in managing fecal incontinence. Acta Obstet Gynecol Scand. 2009;88:766–71. https://doi.
org/10.1080/00016340902993320.
102. Thin NN, Taylor SJC, Bremner SA, et al. Randomized clinical trial of sacral versus percutane­ous tibial nerve stimulation in patients with faecal incontinence. Br J Surg. 2015;102:349–58. https://
doi.org/10.1002/bjs.9695.
103. Urist MM, Maddox WA, Kennedyy JE, Balch CM.Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients. Cancer. 1983;51:2152–6. https://doi.org/10.1002/
1097- 0142(19830601)51:11<2152::AID- CNCR2820 511134>3.0.CO;2- 7.
104. Van der Zee AGJ, Oonk MH, De Hullu JA, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008;26:884–9. https://doi.org/10.1200/
JCO.2007.14.0566.
105. Vignes S, Blanchard M, Yannoutsos A, Arrault M. Complications of autologous lymph-node transplantation for limb lymphoedema. Eur J Vasc Endovasc Surg. 2013;45:516–20. https://doi.
org/10.1016/j.ejvs.2012.11.026.
106. Viitanen TP, Mäki MT, Seppänen MP, et al. Donor-site lymphatic function after microvas­cular lymph node transfer. Plast Reconstr Surg. 2012;130:1246–53. https://doi.org/10.1097/
PRS.0b013e31826d1682.
107. Xu J, Duan K, Guan X, et al. Laparoendoscopic single-site inguinal lymphadenectomy in gynecol­ogy: preliminary experience at a single institution. Arch Gynecol Obstet. 2020;302:497–503. https://
doi.org/10.1007/s00404- 020- 05649- 5.
108. Yao K, Zou Z, Li Z, etal. Fascia lata preservation during inguinal lymphadenectomy for penile cancer: rationale and outcome. Urology. 2013;82:642–7.
https://doi.org/10.1016/j.urology.2013.05.021.
109. Zhang SH, Sood AK, Sorosky JI, etal. Preservation of the saphenous vein during inguinal lymphadenec­tomy decreases morbidity in patients with carcinoma of the vulva. Cancer. 2000;89:1520–5.
110. Zhang X, Sheng X, Niu J, etal. Sparing of saphe­nous vein during inguinal lymphadenectomy for vul­val malignancies. Gynecol Oncol. 2007;105:722–6.
https://doi.org/10.1016/j.ygyno.2007.02.011.
Pelvic andParaaortic Lymphadenectomy
MitchelHoman, MurrayShames, andBernardH.Bochner
32

Introduction

Removal of pelvic and/or paraaortic lymph nodes is an integral part of surgery for gyneco­logic and urologic cancers. For gynecologic malignancies paraaortic lymph nodes are divided into infra- and supramesenteric relative to the bifurcation of the aorta, inferior mesenteric artery (IMA), and left renal vein (Fig.32.1). For women with high- risk bladder cancer undergo­ing a radical cystectomy, the pelvic lymphade­nectomy is routinely performed and is divided
into limited, extended and super-extended with the proximal limit of dissection at the common iliac bifurcation, aortic bifurcation, or the base of the IMA respectively [1]. Lymphadenectomy may be performed by open or laparoscopic surgery.
Major complications related to pelvic and paraaortic lymphadenectomy (PPLND) include vascular injury, lymphedema, nerve injury, ure­teral injury, compromise of blood supply to the intestinal tract, injury to the duodenum, arterial embolization, lymphocyst and chylous ascites.
M. Hoffman (*) Department of Gynecologic Oncology, Moftt Cancer Center, USF Morsani College of Medicine, Tampa, FL, USA e-mail: mitchel.hoffman@moftt.org
M. Shames Department of Surgery, Division of Vascular Surgery, USF Morsani College of Medicine, Tampa, FL, USA e-mail: mshames@usf.edu
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2025 M. Hoffman et al. (eds.), Major Complications of Female Pelvic Surgery,
https://doi.org/10.1007/978-3-031-66772-5_32
B. H. Bochner Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA e-mail: bochnerb@mskcc.org
351
352
iliac node
e
Fig. 32.1 Anatomy of the lymphatic system as it relates to pelvic and paraaortic lymphadenectomy. The relationships of the major vasculature, urinary tract and obturator nerves are shown
M. Homan et al.
Periaortic nodes
Common
Anatomy of the pelvic and paraaortic lymph nodes

Vascular Injury

Background

Risk factors for major vascular injury include obesity, obliteration of the retroperitoneum or pel­vic planes (prior surgery, radiation therapy), tumor involvement of the vasculature either via direct extension or involved regional lymph nodes, aberrant anatomy, and utilization of an energy device that may impact tissue beyond what is intended [2]. Although uncommon, major vas­cular injury is the most serious and life- threatening complication of PPLND [3]. Therefore, much of this chapter will focus on vascular injury during the performance of a PPLND.

Prevention

The internal iliac venous plexus is complex, rela­tively delicate, and not easily visualized. This
iliac node Superior external
Internal iliac nod
Inferior external iliac node
Obturator node
Deep femoral nodes
plexus progressively coalesces into the short internal iliac vein. Several venous branches to the internal iliac vein travel in an anterior/posterior plane as they arise from the gluteal compartment. Injury to the more cephalad and coalescing por­tion of this plexus is more likely to result in sub­stantial hemorrhage that may be difcult to control due to the caliber, anatomic complexity, thin walls, and relative surgical inaccessibility. Control of bleeding is best done prophylactically. The plexus is mainly at risk during the dissection of internal iliac and obturator lymph nodes. Prevention of injury to this plexus begins with appropriate development of the relatively avascu­lar paravesical space, exposing the obturator fossa. When reasonable based on clinical nd­ings, the surgeon should limit dissection to remain supercial to the obturator nerve, with caution moving the cephalad toward the venous conuence. If deeper dissection is needed, a lay­ered approach to dissection of the obturator fossa is optimal [4]. A split and roll technique can be used to free the lymphatic tissues anterior to the